ERF

protein-coding

ETS2 repressor factor, the group of ETS transcription factor family

Gene summary

ETS2 is a transcription factor and protooncogene involved in development, apoptosis, and the regulation of telomerase. The protein encoded by this gene binds to the ETS2 promoter and is a strong repressor of ETS2 transcription. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]

MANE transcript

NM_006494.4

Inheritance

AD

ClinVar variants

P:66U:175B:76

Top phenotype

Chitayat syndrome

gnomAD constraint

pLI —, LoF o/e 0.06

Max pathogenic AF

—

Genomic locus

chr19:42,247,569-42,255,128

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~7.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

craniosynostosis 4DEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0010929

Submitter: G2P

craniosynostosis 4MODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0010929

Submitter: Ambry Genetics

Chitayat syndromeDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014956

Submitter: G2P

Noonan syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0018997

Submitter: PanelApp Australia

Chitayat syndromeMODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0014956

Submitter: Ambry Genetics

craniosynostosis 4STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0010929

Submitter: Genomics England PanelApp

craniosynostosis 4DEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0010929

Submitter: ClinGen

ERF was first reported in relation to autosomal dominant ERF-related craniosynostosis in 2013 (Twigg et al., PMID: 23354439). The phenotypic features of "ERF-related craniosynostosis" often include sagittal or multiple-suture synostosis, Chiari malformation, and language delay. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in the phenotypic and genotypic variability between ERF-related craniosynostosis and Chitayat syndrome. Therefore, the two disease entities have been split. The split curation for autosomal dominant Chitayat syndrome will be curated separately. Ten variants (missense, nonsense, splice, frameshift) that have been reported in 12 probands in 3 publications (PMIDs: 23354439, 26097063, 31754721) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be heterozygous loss of function (haploinsufficiency) (PMID: 23354439). This gene-disease association is supported by an expression study and a conditional mouse model (PMID: 23354439). In summary, ERF is definitively associated autosomal dominant ERF-related craniosynostosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 5/20/2021.

craniosynostosis 4STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0010929

Submitter: Labcorp Genetics (formerly Invitae)

Chitayat syndromeSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014956

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Chitayat syndromeAD

Manifestation: Craniofacial; Musculoskeletal; Neurologic; Pulmonary

Intervention: Pulmonary

Rationale: Among other features, Chitayat syndrome can include neonatal respiratory distress requiring ventilatory support, and awareness may allow early recognition and management

Refs: 8418638; 23354439; 26097063; 27738187Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ERF variants in ClinVar

20 Conditions Cataloged
not providedTotal: 125
TWIST1-related craniosynostosisTotal: 103
Inborn genetic diseasesTotal: 90
Lambdoidal craniosynostosisTotal: 32
not specifiedTotal: 25
ERF-related disorderTotal: 24
Chitayat syndromeTotal: 15
Craniosynostosis 4Total: 9

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006494.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
52
clinvar
5
clinvar
60
missense
1
clinvar
8
clinvar
162
clinvar
18
clinvar
1
clinvar
190
nonsense
8
clinvar
10
clinvar
1
clinvar
19
start loss
2
clinvar
1
clinvar
3
frameshift
13
clinvar
18
clinvar
6
clinvar
37
splice donor/acceptor (+/-2bp)
3
clinvar
2
clinvar
3
clinvar
8
Total2739175706317

Highest pathogenic variant AF is 0.0000031243517

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 18 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006494.4RefSeqNP_006485.24MANE Select
ENST00000222329.9EnsemblENSP00000222329.34MANE Select
NM_001301035.2RefSeqNP_001287964.13Standard
NM_001308402.2RefSeqNP_001295331.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Oncogene Induced Senescence
  • Cellular Senescence
  • Cellular responses to stress
  • Cellular responses to external stimuli

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • mitotic cell cycle
  • regulation of transcription by RNA polymerase II
  • cell differentiation

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription repressor activity, RNA polymerase II-specific
  • transcription corepressor activity
  • sequence-specific DNA binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000222329
Coding exons
4
Length
7586
Individuals with no LoFs
125719
Homozygous LoFs
0
Heterozygous LoFs
4
Defined
125723
p
0.0000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.252383580.6650.00002423427
Missense (PolyPhen)49110.470.443541066
Synonymous-1.841991691.180.00001201236
Loss of Function3.73118.20.05510.00000101196

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000280.000026rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation. Required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment (By similarity). May be important for regulating trophoblast stem cell differentiation (By similarity). {ECO:0000250}.;
Disease
DISEASE: Craniosynostosis 4 (CRS4) [MIM:600775]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:23354439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Chitayat syndrome (CHYTS) [MIM:617180]: An autosomal dominant syndrome characterized by hyperphalangism, partial syndactyly, bilateral accessory phalanx resulting in shortened index fingers, hallux valgus, brachydactyly, facial anomalies, diffuse bronchomalacia, and respiratory distress at birth and in infancy. {ECO:0000269|PubMed:27738187}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.139

Intolerance Scores

LoFtool
0.0200
RVIS EVS
-0.42
RVIS percentile EVS
25.56

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.994

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.